Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      NPPA allows Abbott to withdraw bioresorbable stent from India

      NPPA allows Abbott to withdraw bioresorbable stent from India

      Ruby Khatun Khatun22 Sept 2017 5:00 PM IST
      New Delhi: Through a recent notice, Government of India , Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, and National...
      Zydus Pharma recalls 44.8 K bottles of antidepressant in US

      Zydus Pharma recalls 44.8 K bottles of antidepressant in US

      Ruby Khatun Khatun22 Sept 2017 10:57 AM IST
      New Delhi: Cadila Healthcare's US arm, Zydus Pharmaceuticals USA Inc, is recalling 44,800 bottles of antidepressant Paroxetine tablets from the...
      Glenmark gets USFDA nod for chest pain tablets

      Glenmark gets USFDA nod for chest pain tablets

      Ruby Khatun Khatun22 Sept 2017 10:47 AM IST
      New Delhi: Glenmark Pharmaceuticals on Wednesday said its US arm has received final approval from USFDA for its Nitroglycerin sublingual tablets used...
      Dr Reddys receives EIR for Srikakulam plant, shares soar

      Dr Reddys receives EIR for Srikakulam plant, shares soar

      Ruby Khatun Khatun22 Sept 2017 10:29 AM IST
      New Delhi: Shares of Dr Reddy's Laboratories Ltd soared by 7.5% after the company said it has received establishment inspection report (EIR) from the...
      Biotech interventions to help Assam become organic hub: CM

      Biotech interventions to help Assam become organic hub: CM

      Ruby Khatun Khatun22 Sept 2017 10:19 AM IST
      Guwahati: Aiming to promote business in biotechnology and allied areas through entrepreneurship development, Assam Chief Minister Sarbananda Sonowal...
      Novartis Rydapt wins EU approval for AML, other diseases

      Novartis Rydapt wins EU approval for AML, other diseases

      Ruby Khatun Khatun22 Sept 2017 9:57 AM IST
      ZURICH: Swiss drugmaker Novartis on Wednesday won European Union approval for Rydapt to be used against a mutated form of acute myeloid leukemia (AML)...
      Mankind Pharma in trouble over Sunny Leone Navratri condom ad

      Mankind Pharma in trouble over Sunny Leone Navratri condom ad

      Ruby Khatun Khatun21 Sept 2017 12:34 PM IST
      New Delhi: Traders body CAIT on Tuesday asked the Centre to ban an outdoor advertisement in Gujarat of Manforce contraceptive brand endorsed by...
      MTaI urges govt to look at sub-categorization of devices

      MTaI urges govt to look at sub-categorization of devices

      Ruby Khatun Khatun21 Sept 2017 11:01 AM IST
      New Delhi: The medical technology industry has reached out to the government to look at sub-sectoring and sub-categorization of medical devices on the...
      Strides Shasun gets USFDA nod for lipid lowering drug

      Strides Shasun gets USFDA nod for lipid lowering drug

      Ruby Khatun Khatun21 Sept 2017 10:49 AM IST
      New Delhi: Drug firm Strides Shasun on Wednesday said it has received approval from the United States health regulator for generic Omega-3-acid ethyl...
      NPPA slashes price of 39 drugs: check out details

      NPPA slashes price of 39 drugs: check out details

      Ruby Khatun Khatun21 Sept 2017 10:34 AM IST
      New Delhi: Drug price regulator NPPA on Wednesday said it has fixed the ceiling price for 39 more drug formulations, including those used for the...
      Divis Labs gets 6 USFDA observations for Vizag unit

      Divis Labs gets 6 USFDA observations for Vizag unit

      Ruby Khatun Khatun21 Sept 2017 10:27 AM IST
      New Delhi: Drug firm Divis Laboratories on Thursday said it has received six new observations from the US Food and Drug Administration (USFDA) after...
      Novartis Cosentyx sets new benchmark in psoriasis with robust 5-year sustained Phase III efficacy and safety data

      Novartis Cosentyx sets new benchmark in psoriasis with robust 5-year sustained Phase III efficacy and safety data

      Ruby Khatun Khatun21 Sept 2017 9:57 AM IST
      Basel, September 13, 2017 - Novartis announced, first of its kind Phase III data showing Cosentyx® (secukinumab) delivered high and long-lasting skin...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok